Study Identifies Sudden Death Trigger in Restrictive Cardiomyopathy
A new study to be presented at the annual meeting of the American Heart Association is believed to be the first to define how sudden death is triggered in children with restrictive cardiomyopathy.
The study shows that sudden death in children with restrictive cardiomyopathy, or RCM, can be due to heart block – a slow heart rate. It was previously assumed that most instances of sudden death in children with RCM were due to rapid heart rhythms emanating from the pumping chambers of the heart.
"The mode of death we are seeing in our population is different than previously expected, and was associated with disorders of the conduction system that ultimately lead to heart block. We believe RCM patients diagnosed with additional conduction system disorders should be considered for implantation with ICDs (implantable cardioverter-defibrillators), which can detect both fast and slow heart rhythms allowing for prophylactic protection from both potential mechanisms for sudden death.”
Dr. Czosek and his colleagues at the Cincinnati Children’s Heart Institute reviewed the records of 15 patients with RCM seen at Cincinnati Children’s between April 1994 and April 2011. Five had sudden cardiac events, and four of the five died.
Two of the deaths were precipitated by abrupt, complete heart block. Another had intermittent heart block and survived as a result of an implanted ICD. RCM is the least common cardiomyopathy, but it ultimately leads to heart failure.
When the condition becomes serious enough, it typically requires a heart transplant. While ICDs are often used in patients who are at risk of sudden death, they are also used in children as a bridge to transplant, delaying the need for transplant until a suitable heart can be located.
Other authors of the study include Jeffrey Towbin, MD, executive co-director of the Cincinnati Children’s Heart Institute, and John Lynn Jeffries, MD, director of advanced heart failure and cardiomyopathy at the Heart Institute. Lead author of the study is Mark Walsh, MD, who is now at Stollery Children’s Hospital in Edmonton.